Buscar
Mostrando ítems 31-40 de 145
Efeito farmacogenético do polimorfismo Ala16Val do gene da MnSOD na resposta de pacientes hipercolesterolêmicos a rosuvastatina
(Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da Saúde, 2015-02-27)
Rosuvastatin is used as a drug of first choice in treating hypercholesterolemia due to
competitive inhibition of HMG-CoA reductase enzyme which converts HMG-CoA to
mevalonic acid which is the rate-limiting step in ...
Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study
(Associação Brasileira de Divulgação Científica, 2008)
We investigated whether chronic rosuvastatin administration could improve the abnormalities of the circulating levels of vascular dysfunction markers in pulmonary arterial hypertension (PAH). Sixty patients, aged 13 to 60 ...
Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits
(Elsevier Gmbh, Urban & Fischer VerlagJenaAlemanha, 2013)
SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC
(Sociedad Chilena de Química, 2010)
Rosuvastatin: role in cardioascular high-risk patient
(Facultad de Medicina. Universidad Nacional de Colombia. Sede Bogotá, 2013)
Las estatinas son la familia farmacológica hipolipemiantede primera opción en situaciones de hipercolesterolemia odislipiemia mixta con predominio de aumento en el colesterol.La evidencia demuestra contundentemente que ...
Rosuvastatin Given During Reperfusion Decreases Infarct Size and Inhibits Matrix Metalloproteinase-2 Activity in Normocholesterolemic and Hypercholesterolemic Rabbits
(Lippincott Williams, 2009-02)
There is evidence that statin treatment before ischemia protects myocardium from ischemia/reperfusion injury. Objective: to determine whether rosuvastatin administered during reperfusion modifies infarct size and the ...
Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore
(Servicio Publicaciones Universidad Navarra, 2020-01)
The cardioprotective activity of rosuvastatin (R) is yet to be known. The objective of this study was to research whether R perfusion before global ischemia can mitigate myocardial ischemia-reperfusion damage, considering ...